Arbutus Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2008
Cash & Equivalents	26.29	30.78	109.28	52.25	31.8	36.94	54.29	23.41	166.78	72.19	Upgrade
Short-Term Investments	99.72	116.14	46.04	71.02	59.04	87.68	72.06	107.15	14.53	39.97	Upgrade
Cash & Cash Equivalents	126	146.91	155.32	123.27	90.83	124.62	126.35	130.56	181.3	112.16	Upgrade
Cash Growth	-14.23%	-5.41%	26.00%	35.71%	-27.11%	-1.37%	-3.22%	-27.99%	61.65%	63.22%	Upgrade
Receivables	1.78	1.35	0.9	1.31	1.2	1.43	0.53	0.4	1.14	2.44	Upgrade
Other Current Assets	4.25	2.87	4.45	3.12	1.79	3.18	2.48	1.6	1.44	1.82	Upgrade
Total Current Assets	132.03	151.14	160.66	127.7	93.83	129.23	129.37	132.56	183.88	116.42	Upgrade
Property, Plant & Equipment	6.09	6.81	8.08	9.33	11.41	10.15	12.18	6.95	3.18	1.76	Upgrade
Long-Term Investments	6.28	37.36	35.69	0	0	22.22	12.6	12.6	10.07	0	Upgrade
Goodwill and Intangibles	0	0	0	0	0	66.31	83.01	123.81	515.16	0	Upgrade
Other Long-Term Assets	0	0.1	0.06	0.04	0.29	0	0	0	0	0	Upgrade
Total Long-Term Assets	12.37	44.28	43.82	9.38	11.71	98.68	107.8	143.36	528.41	1.76	Upgrade
Total Assets	144.4	195.42	204.49	137.08	105.54	227.91	237.16	275.92	712.29	118.18	Upgrade
Accounts Payable	10.27	16.03	10.84	9.15	7.24	9.43	10.65	9.91	8.83	9.33	Upgrade
Deferred Revenue	11.79	22.46	0	0	0	0	2.74	0.02	1.08	15.72	Upgrade
Current Debt	0.43	0.37	0.38	0.39	0.34	0	0	0	0	0	Upgrade
Other Current Liabilities	0	-6	0	0	0.25	1.81	1.24	0.66	0.67	-4.84	Upgrade
Total Current Liabilities	22.49	32.86	11.22	9.54	7.83	11.24	14.63	10.59	10.58	20.21	Upgrade
Long-Term Debt	1.34	1.82	2.23	2.59	3.02	0	12	12	0	0	Upgrade
Other Long-Term Liabilities	14.55	23.9	21.59	22.98	21.95	16.43	28.06	50.33	154.03	9.94	Upgrade
Total Long-Term Liabilities	15.9	25.71	23.83	25.57	24.96	16.43	40.06	62.33	154.03	9.94	Upgrade
Total Liabilities	38.38	58.57	35.05	35.11	32.79	27.67	54.69	72.91	164.61	30.14	Upgrade
Total Debt	1.77	2.19	2.61	2.98	3.36	0	12	12	0	0	Upgrade
Debt Growth	-19.16%	-16.34%	-12.37%	-11.17%	-	-	-	-	-	-	Upgrade
Retained Earnings	-1,276.65	-1,203.8	-1,134.35	-1,045.96	-970.09	-805.22	-738.07	-652.75	-266.99	-205.86	Upgrade
Comprehensive Income	-48.42	-50.49	-48.34	-48.17	-48.23	-48.17	-48.19	-48.19	-49.78	-22.31	Upgrade
Shareholders' Equity	106.02	136.85	169.44	101.97	72.74	200.23	182.47	203.01	547.68	88.04	Upgrade
Net Cash / Debt	124.24	144.73	152.7	120.29	87.48	124.62	114.35	118.56	181.3	112.16	Upgrade
Net Cash / Debt Growth	-14.16%	-5.22%	26.95%	37.51%	-29.80%	8.98%	-3.55%	-34.61%	61.65%	63.22%	Upgrade
Net Cash Per Share	0.75	0.96	1.44	1.59	1.53	2.25	2.09	2.23	3.99	5.19	Upgrade
Working Capital	109.54	118.28	149.44	118.16	86	117.99	114.74	121.98	173.3	96.21	Upgrade
Book Value Per Share	0.64	0.91	1.59	1.34	1.27	3.62	3.33	3.83	12.05	4.08	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).